Safety monitoring of COVID-19 vaccination among adolescents aged 12 to 17 years old in the Republic of Korea

por Kim, Seontae, Hwang, Insob, Ko, Mijeong, Kwon, Yunhyung, Lee, Yeon-Kyeng
Publicado 2022

Household secondary attack rates and risk factors during periods of SARS-CoV-2 Delta and Omicron variant predominance in the Republic of Korea

por Lee, Jin, Ko, Mijeong, Kim, Seontae, Lim, Dosang, Park, Gemma, Lee, Sang-Eun
Publicado 2023

Adverse events of the Pfizer-BioNTech COVID-19 vaccine in Korean children and adolescents aged 5 to 17 years

por Kim, Seontae, Heo, Yeseul, Seo, Soon-Young, Lim, Do Sang, Cho, Enhi, Lee, Yeon-Kyeng
Publicado 2022

Safety surveillance of the NVX-CoV2373 COVID-19 vaccine among Koreans aged 18 years and over

por Kim, Seontae, Ko, Mijeong, Heo, Yesul, Lee, Yeon-Kyeng, Kwon, Yunhyung, Choi, Seok-Kyoung, Bahng, Eunok
Publicado 2023

Self-reported adverse events after 2 doses of COVID-19 vaccine in Korea

por Kwon, Yunhyung, Hwang, Insob, Ko, Mijeong, Kim, Hyungjun, Kim, Seontae, Seo, Soon-Young, Cho, Enhi, Lee, Yeon-Kyeng
Publicado 2022

Safety monitoring of COVID-19 vaccines: February 26, 2021, To June 4, 2022, Republic of Korea

por Lee, Yeon-Kyeng, Kwon, Yunhyung, Heo, Yesul, Kim, Eun Kyoung, Kim, Seung Yun, Cho, Hoon, Kim, Seontae, Ko, Mijeong, Lim, Dosang, Seo, Soon-Young, Cho, Enhi
Publicado 2023